"Designing Growth Strategies is in our DNA"

Skin Cancer Treatment Market Size, Share & Industry Analysis, By Disease Indication (Melanoma and Non-Melanoma), By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102806

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Skin Cancer - by Region
    2. Key Mergers, Acquisition, and Partnerships
    3. Pipeline Analysis
    4. New Product Introductions/ Approvals- by Major Players
    5. Overview of Regulatory Scenario - Key Countries
  5. Global Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis, Insights and Forecast – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Merck & Co.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Bristol Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. GlaxoSmithKline plc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Regeneron Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Skin Cancer Treatment Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 3:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Melanoma, 2016-2027

Figure 4:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Non-melanoma, 2016-2027

Figure 5:  Global Skin Cancer Treatment Market Value Share (%), by Therapy, 2019 & 2027

Figure 6:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Immunotherapy, 2016-2027

Figure 7:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Targeted Therapy, 2016-2027

Figure 8:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Chemotherapy, 2016-2027

Figure 9:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Radiation Therapy, 2016-2027

Figure 10:  Global Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 11:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Hospital Pharmacy , 2016-2027

Figure 12:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Retail Pharmacy , 2016-2027

Figure 13:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Others, 2016-2027

Figure 14:  Global Skin Cancer Treatment Market Value (US$ Bn), by Region, 2019 & 2027

Figure 15:  North America Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 16:  North America Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 17:  North America Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 18:  North America Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 19:  North America Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 20:  North America Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 21:  North America Skin Cancer Treatment Market Value (US$ Bn), By Country, 2019 & 2027

Figure 22:  North America Skin Cancer Treatment Market Value Share (%), By Country, 2019

Figure 23:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 24:  Europe Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 25:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 26:  Europe Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 27:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 28:  Europe Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 29:  Europe Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 30:  Europe Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 32:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 33:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 34:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 35:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 36:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 38:  Asia Pacific Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 40:  Latin America Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 41:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 42:  Latin America Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 43:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Modality, 2019 & 2027

Figure 44:  Latin America Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 46:  Latin America Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 48:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 49:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 50:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 51:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 52:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 53:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 54:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 55:  Global Skin Cancer Treatment Market Share (%), By Company, 2019

Table 1:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016–2027

Table 2:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 3:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016–2027

Table 4:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 5:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 7:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 8:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 9:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 12:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 13:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 14:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 17:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 18:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 19:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 22:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 23:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 24:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 27:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 28:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 29:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Skin Cancer Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase